- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03276767
Comparing SMS and E-mail Reminders in an Online Smoking Cessation Intervention
An RCT Comparing Reminders Sendt by SMS or by E-mail in an Online Smoking Cessation Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Web- and mobile phone health behavior change interventions, including smoking cessation programs, offer great promise, but little is known about how such interventions should be designed to increase user engagement. The primary purpose of the current study is to compare the effect of SMS-textmessage vs e-mail reminders on user engagement and proportion of reported quit attempts in an online smoking cessation intervention.
The investigators propose a 2-arm RCT with 700 adult study participants that all receive a best practices web-based smoking cessation program designed for use on smart phones (web-app). The intervention includes a ten day preparation phase, in which participants continue smoking. On the eleventh day (and onward) the user will receive a session in which (s)he is asked whether (s)he has quit smoking or not. If not, the user will receive additional treatment sessions until (s)he reports having quit (or dropped out of the study). Each day (for up to 14 days) a new unique session is assigned to the user. However, if the user does not log on to the web-intervention and starts using the session by noon on the second day after assignment, the user will receive a reminder to do so. When a user is to be sent a reminder for the first time, (s)he will be randomized to either receive such reminders by SMS or by e-mail.
The primary outcome is reporting a quit attempt or not. Secondary outcomes include number web-sessions started and completed and time spent navigating sessions after the first reminder is received.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Håvar Brendryen, PhD
- Phone Number: +47 99521714
- Email: brendryen@gmail.com
Study Locations
-
-
-
Praha, Czechia
- Not yet recruiting
- Department of Addictology, 1st Faculty of Medicine, Charles University
-
Contact:
- Roman Gabrhelík, PhD
- Email: gabrhelik@adiktologie.cz
-
-
-
-
-
Oslo, Norway
- Recruiting
- The Norwegian Centre for Addiction Research
-
Contact:
- Håvar Brendryen, PhD
- Phone Number: +47 99521714
- Email: brendryen@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older
- current smoker
- determined to or considering to quit smoking
- provide valid e-mail address
- provide valid norwegian cell phone number
- complete a baseline questionnaire
- start using the intervention (pushing the next page button one time or more on the first session provided)
- has not logged on to any of the online session within noon on the second day after that particular session was made available
Exclusion Criteria:
- Not starting the first treatment session
- Taking every treatment session on time (no need for reminders, and thus not randomized)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Online intervention with SMS reminder
Reminders will be sendt by SMS-TEXTMESSAGE if users of "Endre" does not log on to an assigned online session by noon on the second day.
|
The online intervention, "Endre", a digital smoking cessation counsellor that communicates with the user primarily through interactive web-sessions.
Intervention content is tailored based on user input and individual usage pattern.
Up to 14 unique sessions is assigned to the users during the study period, one each day.
If a user does not start a session by noon on the second day a reminder will be sendt.
|
Active Comparator: Online intervention with e-mail reminder
Reminder will be sendt by E-MAIL if users of "Endre" does not log on to an assigned online session by noon on the second day.
|
The online intervention, "Endre", a digital smoking cessation counsellor that communicates with the user primarily through interactive web-sessions.
Intervention content is tailored based on user input and individual usage pattern.
Up to 14 unique sessions is assigned to the users during the study period, one each day.
If a user does not start a session by noon on the second day a reminder will be sendt.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quit attempt
Time Frame: Within 6 weeks after starting the first session of the intervention
|
User report a quit attempt
|
Within 6 weeks after starting the first session of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of sessions completed
Time Frame: Within 6 weeks after starting the first session of the intervention
|
Counted from after first reminder until reported quitting or study dropout (a unique session is made available each day)
|
Within 6 weeks after starting the first session of the intervention
|
Number of sessions started after first reminder
Time Frame: Within 6 weeks after starting the first session of the intervention
|
Counted from after first reminder until reported quitting or study dropout (a unique session is made available each day)
|
Within 6 weeks after starting the first session of the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Håvar Brendryen, PhD, University of Oslo
Publications and helpful links
General Publications
- Holter MT, Johansen A, Brendryen H. How a Fully Automated eHealth Program Simulates Three Therapeutic Processes: A Case Study. J Med Internet Res. 2016 Jun 28;18(6):e176. doi: 10.2196/jmir.5415.
- Kulhanek A, Lukavska K, Gabrhelik R, Novak D, Burda V, Prokop J, Holter MTS, Brendryen H. Comparing Reminders Sent via SMS Text Messaging and Email for Improving Adherence to an Electronic Health Program: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Mar 18;10(3):e31040. doi: 10.2196/31040.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NFR 228158/H10-C
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nicotine Dependence Tobacco Product
-
Juul Labs, Inc.CelerionCompletedTobacco Use | Smoking, Tobacco | Nicotine Dependence, Other Tobacco ProductUnited States
-
Juul Labs, Inc.Rose Research Center, LLCCompletedTobacco Use | Tobacco Smoking | Nicotine Dependence, Other Tobacco ProductUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Yale UniversityCompletedNicotine Dependence, Other Tobacco ProductUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedSmoking | Nicotine Dependence | Nicotine Dependence, Other Tobacco ProductUnited States
-
Indiana UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Dartmouth-Hitchcock Medical CenterCompletedLung Cancer | Bladder Cancer | Cancer of Head and Neck | Nicotine Dependence, Other Tobacco ProductUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesNew Zealand
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesNew Zealand
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)WithdrawnCardiovascular Risk Factor | Nicotine Dependence | Nicotine Dependence, Cigarettes | Nicotine Withdrawal | Tobacco ToxicityUnited States
Clinical Trials on Endre
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruitingNicotine Dependence, CigarettesCzechia, Norway
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruiting